Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer

被引：0
作者：
Zhuowei Gu
Yifeng He
Yue Zhang
Mo Chen
Keqi Song
Yuting Huang
Qing Li
Wen Di
机构：
[1] Shanghai Jiao Tong University,Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine
[2] Shanghai Jiao Tong University,Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine
[3] University of Pennsylvania,Tumor Microenvironment and Metastasis Program, The Wistar Institute
[4] Shanghai Jiao Tong University,Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology
[5] Fudan University,Department of Gynecology, Obstetrics and Gynecology Hospital
[6] Children’s National Medical Center,Children’s Research Institute
[7] Shanghai Jiao Tong University,State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine
来源：
Journal of Translational Medicine | / 16卷
关键词：
Ovarian cancer; CA125; Fasting; Postprandial; Increment; Glucose; Insulin; PI3K; Akt; Mesothelin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 158 条
  • [1] Prorok PC(2000)Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial Control Clin Trials 21 273S-309S
  • [2] Andriole GL(2009)Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses Ultrasound Obstet Gynecol 34 462-470
  • [3] Bresalier RS(2009)Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Br J Cancer 100 1315-1319
  • [4] Buys SS(1990)Preoperative serum tumor-associated antigen levels in women with pelvic masses Obstet Gynecol 75 249-254
  • [5] Chia D(2014)Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies Front Surg 1 14-2844
  • [6] Crawford ED(2010)Prevalence, incidence, and natural history of simple ovarian cysts among women > age 55 years old in a large cancer screening trial Am J Obstet Gynecol 202 373.e1-9-1446
  • [7] Sokalska A(2001)OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal Cancer 92 2837-3700
  • [8] Timmerman D(2012)Diagnostic value of HE4 for ovarian cancer: a meta-analysis Clin Chem Lab Med 50 1439-281
  • [9] Testa AC(2003)The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Res 63 3695-491
  • [10] Van Holsbeke C(2013)Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review J Clin Pathol 66 273-96
12345678910